Evidence map›Paper›PMID 41343530›Full record

ArticlePloS one2025

Proinflammatory gene and protein expression alterations in human limbal aniridia fibroblasts.

Julia Sarah Alexandra Zimmermann, Simon Trusen, Fabian Norbert Fries, Zhen Li, Ning Chai, Berthold Seitz, Shweta Suiwal, Maryam Amini, Nóra Szentmáry, Tanja Stachon

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Julia Sarah Alexandra ZimmermannDr. Rolf M. Schwiete Center for Limbal Stem Cell and Aniridia Research, Saarland, University, Homburg/Saar, Germany.ORCID https://orcid.org/0009-0007-5832-7152
Simon TrusenDr. Rolf M. Schwiete Center for Limbal Stem Cell and Aniridia Research, Saarland, University, Homburg/Saar, Germany.
Fabian Norbert FriesDr. Rolf M. Schwiete Center for Limbal Stem Cell and Aniridia Research, Saarland, University, Homburg/Saar, Germany.ORCID https://orcid.org/0000-0002-8526-4712
Zhen LiDr. Rolf M. Schwiete Center for Limbal Stem Cell and Aniridia Research, Saarland, University, Homburg/Saar, Germany.
Ning ChaiDr. Rolf M. Schwiete Center for Limbal Stem Cell and Aniridia Research, Saarland, University, Homburg/Saar, Germany.ORCID https://orcid.org/0000-0001-9689-8887
Berthold SeitzDepartment of Ophthalmology, Saarland University Medical Center, Homburg/Saar, Germany.
Shweta SuiwalDr. Rolf M. Schwiete Center for Limbal Stem Cell and Aniridia Research, Saarland, University, Homburg/Saar, Germany.
Maryam AminiDr. Rolf M. Schwiete Center for Limbal Stem Cell and Aniridia Research, Saarland, University, Homburg/Saar, Germany.
Nóra SzentmáryDr. Rolf M. Schwiete Center for Limbal Stem Cell and Aniridia Research, Saarland, University, Homburg/Saar, Germany.
Tanja StachonDr. Rolf M. Schwiete Center for Limbal Stem Cell and Aniridia Research, Saarland, University, Homburg/Saar, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aniridia-associated keratopathy (AAK) results from the paired box 6 (PAX6) gene haploinsufficiency, leading to depletion of limbal epithelial stem cells, persistent inflammation and a gradual loss of vision. Although fibroblasts are acknowledged as sentinel cells initiating corneal inflammation, their contribution in the chronic inflammatory state of AAK remains unexplored. Our study aims to compare PAX6 and inflammatory cytokine expression in limbal fibroblast cells (LFCs) of corneal donors and aniridia patients (AN-LFCs). Furthermore, we subjected LFCs and AN-LFCs to LPS and cobalt chloride (CoCl2), to investigate specific inflammatory reactions. Following isolation and culture, primary LFCs (n = 7) and AN-LFCs (n = 7) were subjected to a 24-hour treatment with E. coli LPS or a 48-hour exposure to CoCl2 as a chemical oxidative stress (OS) inducer. Subsequently, PAX6 as well as IL-1β, IL-6, TNF-α, and VEGF gene expression was examined by qPCR. Corresponding protein levels were assessed by ELISA from the cell culture supernatants. AN-LFCs exhibited similar PAX6 mRNA levels as normal LFCs (p ≥ 0.38). Notably, LPS treatment (p ≤ 0.02), but not CoCl2, significantly enhanced PAX6 expression. Untreated AN-LFCs showed higher IL-6 mRNA (p = 0.002) and protein levels (p = 0.009) but lower TNF-α protein expression (p = 0.016) than LFCs. When exposed to LPS, AN-LFCs exhibited higher IL-1β mRNA (p = 0.0008), as well as IL-6 protein expression (p = 0.029) than normal LFCs. Under OS, an elevated IL-6 protein (p = 0.010) was observed in AN-LFCs compared to LFCs. Our study revealed inflammatory gene and protein expression alterations in AN-LFCs, that could be involved in the stromal niche perturbations seen in AAK.

Indexed as

AniridiaFibroblastsLimbus CorneaeAdultCells, CulturedCobaltCytokinesFemaleGene Expression RegulationHumansInflammationInterleukin-6LipopolysaccharidesMaleMiddle AgedPAX6 Transcription FactorCobaltcobaltous chlorideCytokinesInterleukin-6LipopolysaccharidesPAX6 protein, humanPAX6 Transcription FactorTumor Necrosis Factor-alphaVascular Endothelial Growth Factor A

Identifiers

PMID41343530
PMCPMC12677563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.